Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study

Katarzyna Muras-Szwedziak; Maciej Wójcik; Olga Wojtyczka; Krzysztof Kaczmarek

doi:10.12659/AJCR.945873

17 March 2025 : Case report Poland

Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease

Katarzyna Muras-Szwedziak

^{ABCDEF 1}, Maciej Wójcik

^{ABCDEF 2}, Olga Wojtyczka

^{ABCDEF 2*}, Krzysztof Kaczmarek

^{ABCDEF 3}

DOI: 10.12659/AJCR.945873

Am J Case Rep 2025; 26:e945873

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Cardiac MRI performed before heart transplantation of the patient. The subendomyocardial late gadolinium enhancement can be seen in infero-lateral segments of the left ventricle.

Back to the Article

Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study

Your Privacy